Her2 Expression in Prostatic Cancer:

This publication has 16 references indexed in Scilit:

• Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer
  Urology, 2001
• Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer
  JNCI Journal of the National Cancer Institute, 2000
• HER2 in Prostate Cancer--a Viable Target or Innocent Bystander?
  JNCI Journal of the National Cancer Institute, 2000
• Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells
  Oncogene, 2000
• Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer
  International Journal of Cancer, 1999
• From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
  Proceedings of the National Academy of Sciences, 1999
• A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
  Nature Medicine, 1999
• RECOMBINANT ONCOTOXIN AR209 (ANTI-P185 ^erbB-2 ) DIMINISHES HUMAN PROSTATE CARCINOMA XENOGRAFTS
  Journal of Urology, 1999
• Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma
  Cancer, 1997
• c-erbB-2 oncoprotein: A potential biomarker of advanced prostate cancer
  The Prostate, 1997